Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/bergenbio-second-quarter-results-2024-solid-clinical-and-financial-progress-302227209.html
https://www.prnewswire.com/news-releases/bergenbio-collaborates-with-tempus-to-potentially-accelerate-development-in-stk11m-non-small-cell-lung-cancer-302226095.html
https://www.prnewswire.com/news-releases/bergenbio-second-quarter-results-2024-solid-clinical-and-financial-progress-302227207.html
https://www.prnewswire.com/news-releases/bergenbio-announces-selection-of-2nd-dose-in-phase-2a-first-line-stk11m-non-small-lung-cancer-trial-302208346.html
https://www.prnewswire.com/news-releases/bergenbio-reports-third-quarter-2023-financial-results-301987030.html
https://www.prnewswire.com/news-releases/bergenbio-announces-data-from-biomarker-analyses-in-2l-nsclc-301978174.html
https://www.prnewswire.com/news-releases/bergenbio-announces-poster-presentation-at-upcoming-sitc-meeting-301972852.html
https://www.prnewswire.com/news-releases/additional-data-on-bergenbios-selective-axl-inhibitor-bemcentinib-to-be-presented-at-the-2023-esmo-meeting-301957048.html
https://www.prnewswire.com/news-releases/bergenbio-asa-approval-and-publication-of-prospectus-for-the-preferential-rights-issue-301835679.html
https://www.prnewswire.com/news-releases/bergenbio-presents-data-on-stk11-loss-of-function-and-axl-activation-at-aacr-301799845.html